CN Patent
CN111699175B — 前列环素受体受体激动剂
Assigned to Medshine Discovery Inc · Expires 2022-03-29 · 4y expired
What this patent protects
式(Ⅰ)所示化合物、其异构体或其药学上可接受的盐,并涉及其在制备治疗与PGI 2 受体相关疾病药物中的应用。
USPTO Abstract
式(Ⅰ)所示化合物、其异构体或其药学上可接受的盐,并涉及其在制备治疗与PGI 2 受体相关疾病药物中的应用。
Drugs covered by this patent
- Uptravi (SELEXIPAG) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.